Crown Bioscience promotes Alex Slater to Chief Business Officer, reinforcing global commercial excellence and client-focused growth in oncology CRO services.
Crown Bioscience, a JSR Life Sciences company, earns Fierce CRO Award for global operations excellence in oncology and immuno-oncology drug development services.
Crown Bioscience and NEXT Oncology renew collaboration, combining global clinical trial expertise and innovative cancer models for oncology drug development.
Crown Bioscience appoints John Gu as CEO, leveraging his expertise in AI-driven drug discovery to advance biotechnological innovation and global health.
